| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Divisions of Functional Foods Research and of Nutrition and Chronic Disease, Pennington Biomedical Research Center, Baton Rouge, LA
Background: Although reductions in total and saturated fat consumption are recommended to reduce the risk of cardiovascular disease, individual variability in plasma lipid responses exists.
Objective: Our aim was to determine the effect of adiposity and insulin resistance on the lipoprotein response to diets lower in total and saturated fat than the average American diet (AAD).
Design: A randomized, double-blind, 3-period crossover controlled feeding design was used to examine the effects on plasma lipids of 3 diets that differed in total fat: the AAD [designed to contain 38% fat and 14% saturated fatty acids (SFAs)], the Step I diet (30% fat with 9% SFAs), and the Step II diet (25% fat with 6% SFAs). The diets were fed for 6 wk each to 86 free-living, healthy men aged 22–64 y at levels designed to maintain weight.
Results: Compared with the AAD, the Step I and Step II diets lowered LDL cholesterol by 6.8% and 11.7%, lowered HDL cholesterol by 7.5% and 11.2%, and raised triacylglycerols by 14.3% and 16.2%, respectively. The Step II diet response showed significant positive correlations between changes in both LDL cholesterol and the ratio of total to HDL cholesterol and baseline percentage body fat, body mass index, and insulin. These associations were largely due to smaller reductions in LDL cholesterol with increasing percentage body fat, body mass index, or insulin concentrations. Subdivision of the study population showed that the participants in the upper one-half of fasting insulin concentrations averaged only 57% of the reduction in LDL cholesterol with the Step II diet of the participants in the lower half.
Conclusion: Persons who are insulin resistant respond less favorably to Step II diets than do those who are insulin sensitive.
Key Words: Dietary fat • saturated fat • obesity • adiposity • insulin resistance • metabolic syndrome • blood lipids • diet response
Related articles in AJCN:
This article has been cited by other articles:
|
|
 |
|
  J. M Ordovas Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1509S - 1517S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Becker, R. Y. Gordon, P. B. Morris, J. Yorko, Y. J. Gordon, M. Li, and N. Iqbal Simvastatin vs Therapeutic Lifestyle Changes and Supplements: Randomized Primary Prevention Trial Mayo Clin. Proc., July 1, 2008; 83(7): 758 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M Zivkovic, J B. German, and A. J Sanyal Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease Am. J. Clinical Nutrition, August 1, 2007; 86(2): 285 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Giugliano and K. Esposito Is the whole-diet approach better than a low-fat diet in cardiovascular risk reduction? Am. J. Clinical Nutrition, April 1, 2006; 83(4): 921 - 921. [Full Text] [PDF]
|
|
|
|
|
|
M. Lefevre and C. Champagne Reply to D Giugliano and K Esposito Am. J. Clinical Nutrition, April 1, 2006; 83(4): 921 - 922. [Full Text] [PDF]
|
|
|
|
|
|
J. M Ordovas Diet-heart hypothesis: will diversity bring reconciliation? Am. J. Clinical Nutrition, November 1, 2005; 82(5): 919 - 920. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
